HSP70 was also found to induce STAT5 expression and drug resistance in AML and CML cells and inhibition of STAT5 activity was sufficient to resensitize resistant leukemic cells to chemotherapy [34,38]. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.